INmune Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.
INMB Key Statistics
Stock Snapshot
INmune Bio(INMB) stock is priced at $1.29, giving the company a market capitalization of 34.96M. It carries a P/E multiple of -0.61.
During the trading session on 2026-03-10, INmune Bio(INMB) shares reached a daily high of $1.39 and a low of $1.16. At a current price of $1.29, the stock is +11.2% higher than the low and still -6.9% under the high.
Trading volume for INmune Bio(INMB) stock has reached 866.84K, versus its average volume of 639.53K.
The stock's 52-week range extends from a low of $1.16 to a high of $11.64.
The stock's 52-week range extends from a low of $1.16 to a high of $11.64.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.